What is the clinical evidence from this study?

Study design: Review. Population: Heart Failure and Obesity. Intervention: Weight loss interventions (lifestyle, pharmacological, bariatric surgery).

January 1, 2025Methodist DeBakey Cardiovascular Journal8 citationsOpen Access

The Impact of Obesity on Cardiovascular Diseases: Heart Failure

HAHatem Alansari GLGina Lazzara MTMohamad B. Taha

Key Result

Weight loss interventions, including lifestyle modifications, pharmacological treatments, and bariatric surgery, improve cardiac function and reduce hospitalizations in patients with obesity and heart failure.

Structured PICO

Do weight loss interventions improve outcomes in patients with obesity and heart failure?

Population

Patients with obesity and heart failure (including both HFrEF and HFpEF)

Intervention

Weight loss interventions including lifestyle changes, pharmacological agents (e.g., GLP-1 receptor agonists), and bariatric surgery

Addressing obesity in heart failure patients through multidisciplinary weight management strategies is essential for improving cardiovascular health and optimizing advanced therapies.

Limitations

Reliance on BMI to classify obesity in studies, which does not differentiate between fat mass, fat-free mass, and lean mass
Selection bias in obesity paradox studies, as obese patients who survive to develop HF may represent a healthier subset
Residual confounding such as differences in comorbidities, socioeconomic factors, and healthcare access

Abstract

Obesity and heart failure (HF) are two intersecting public health challenges, each with rising prevalence worldwide. Obesity alters cardiac structure and function, leading to ventricular systolic and diastolic dysfunction. However, weight loss interventions, whether through lifestyle changes, pharmacological agents, or bariatric surgery, can improve cardiac function, reduce symptoms, and lower hospitalization rates. Interestingly, the "obesity paradox" suggests that HF patients with obesity may experience better survival outcomes than HF patients with normal weight despite the adverse cardiac effects of obesity. Most importantly, focusing on strategies that aim to prevent HF in patients with obesity can potentially curb the burden of this chronic condition. This review explores the complex relationship between obesity and HF, emphasizing pathophysiological mechanisms, the paradoxical survival benefit, and the impact of weight loss strategies. A deeper understanding of this relationship is critical for optimizing care and outcomes in HF patients with obesity.

Ask AI

Helpful

Bookmark

View Full Paper